ResMed(NYSE: RMD), amedical device company focused on sleep apnea and chronic obstructive pulmonary disease, reported its first-quarter results after the market closed on Thursday, April 27. While ...
Zacks Investment Research on MSN
BSX vs. RMD: Which medical device stock is the stronger play now?
Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations of $142.4 billion and $35.72 billion, respectively. Marlborough, MA-based ...
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has ...
Zacks Investment Research on MSN
3 stocks likely to gain from rising HSA contribution & Medicare premium
As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...
ResMed Inc.’s (NYSE: RMD) CEO Mick Farrell revealed that Tesla can help manufacture ventilator components along with other automakers and aerospace companies. What Happened Appearing on CNBC’s “Mad ...
ResMed dominates an enormous, underdiagnosed market with recurring revenue and digital health leadership, yet trades below its historical earnings multiples, offering compelling value. The company’s ...
NEW DELHI--(BUSINESS WIRE)--ResMed, a world leader in connected health solutions for sleep apnea, lung disease, and other chronic diseases, today announced the appointment of Shubhi Khurana as general ...
ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...
Sleep apnea technology firm ResMed posted better-than-expected financial results for its fiscal second quarter on strong sales of new, lighter weight mask products and accessories. The San Diego ...
SEOUL--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the ...
Total revenue increased by more than 13% thanks in part to last year's $800 million acquisition of software-as-a-service business Brightree. Excluding the acquisition, revenue grew by 5% in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback